Back to search

Association of Epigenetic Inactivation of RASSF1A with Poor Outcome in Human Neuroblastoma

Data up to Jan 2025

Published2004
Citations87
References39

Total Citations Per Year

Abstract

References (39)

The fundamental role of epigenetic events in cancer

2002 • 5,532 citations

Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage

1984 • 2,248 citations

A gene hypermethylation profile of human cancer.

2001 • 2,043 citations

Principles and Practice of Pediatric Oncology

1990 • 2,002 citations

Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas

1985 • 1,989 citations

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

1999 • 1,843 citations

Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

1973 • 1,284 citations

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

2000 • 1,073 citations

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

2000 • 799 citations

Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

2001 • 770 citations

Molecular Biology of Neuroblastoma

1999 • 644 citations

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

1991 • 595 citations

Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma

1999 • 543 citations

Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages.

1989 • 466 citations

The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation

2002 • 389 citations

Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.

1999 • 366 citations

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex

2004 • 311 citations

The candidate tumor suppressor gene, RASSF1A , from human chromosome 3p21.3 is involved in kidney tumorigenesis

2001 • 296 citations

CpG island methylation in premalignant stages of gastric carcinoma.

2001 • 296 citations

Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.

1999 • 285 citations

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

2002 • 223 citations

Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.

1998 • 221 citations

The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1

2002 • 217 citations

Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer

1990 • 203 citations

Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma

2003 • 175 citations

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

1991 • 142 citations

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

2001 • 137 citations

Beyond the genetic lesions: gene inactivation by promoter hypermethylation in human cancer

2000 • 127 citations

Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.

1994 • 111 citations

Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.

2003 • 109 citations

Genetic Staging of Unresectable or Metastatic Neuroblastomain Infants: a Pediatric Oncology Group Study

1997 • 108 citations

Natural History and Biology of Stage A Neuroblastoma: A Pediatric Oncology Group Study

2000 • 99 citations

Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma

2003 • 90 citations

Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.

1990 • 86 citations

Clustering of hypermethylated genes in neuroblastoma

2003 • 83 citations

Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.

1991 • 62 citations

Combined M‐FISH and CGH analysis allows comprehensive description of genetic alterations in neuroblastoma cell lines

2001 • 50 citations

Comparative genomic hybridization analysis of human neuroblastomas: Detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines

1997 • 47 citations

Hypermethylation‐mediated regulation of CD44 gene expression in human neuroblastoma

2002 • 39 citations

Cited By (0)

Loading...
Association of Epigenetic Inactivation of RASSF1A with Poor Outcome in Human Neuroblastoma (2004) – Clinical Cancer Research | Metascience Observatory Explorer